These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30126643)

  • 1. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records.
    Vihta KD; Stoesser N; Llewelyn MJ; Quan TP; Davies T; Fawcett NJ; Dunn L; Jeffery K; Butler CC; Hayward G; Andersson M; Morgan M; Oakley S; Mason A; Hopkins S; Wyllie DH; Crook DW; Wilcox MH; Johnson AP; Peto TEA; Walker AS
    Lancet Infect Dis; 2018 Oct; 18(10):1138-1149. PubMed ID: 30126643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis.
    Bryce A; Hay AD; Lane IF; Thornton HV; Wootton M; Costelloe C
    BMJ; 2016 Mar; 352():i939. PubMed ID: 26980184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.
    Schlackow I; Stoesser N; Walker AS; Crook DW; Peto TE; Wyllie DH;
    J Antimicrob Chemother; 2012 Jun; 67(6):1514-24. PubMed ID: 22438437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): a quasi-experimental, ecological, data linkage study.
    Aliabadi S; Anyanwu P; Beech E; Jauneikaite E; Wilson P; Hope R; Majeed A; Muller-Pebody B; Costelloe C
    Lancet Infect Dis; 2021 Dec; 21(12):1689-1700. PubMed ID: 34363774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn R; McDermott TE; Murphy P; Grainger R; Fennell JP; Thornhill JA
    Ir J Med Sci; 2013 Mar; 182(1):81-9. PubMed ID: 22669684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Escherichia coli urinary tract infection: susceptibility trends and clinical management-a retrospective analysis of a 10-year period.
    Whelan SO; Kyne S; Dore A; Glynn M; Higgins F; Hanahoe B; Moriarty F; Moylett E; Cormican M
    Ir J Med Sci; 2024 Aug; 193(4):1891-1900. PubMed ID: 38565823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection.
    Leflon-Guibout V; Ternat G; Heym B; Nicolas-Chanoine MH
    J Antimicrob Chemother; 2002 Feb; 49(2):367-71. PubMed ID: 11815581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Amoxiclav as empiric treatment of UTI in children: importance of surveillance in ensuring optimal empiric treatment choice.
    Trayer J; Horgan M; Prior AR; Ryan M; Nadeem M
    Int J Clin Pharm; 2022 Feb; 44(1):256-259. PubMed ID: 34423380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
    BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
    McCowan C; Bakhshi A; McConnachie A; Malcolm W; Barry SJ; Santiago VH; Leanord A
    BMC Infect Dis; 2022 Oct; 22(1):805. PubMed ID: 36307776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK.
    Lipworth S; Vihta KD; Chau K; Barker L; George S; Kavanagh J; Davies T; Vaughan A; Andersson M; Jeffery K; Oakley S; Morgan M; Hopkins S; Peto TEA; Crook DW; Walker AS; Stoesser N
    Genome Med; 2021 Sep; 13(1):144. PubMed ID: 34479643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.
    Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ
    Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia.
    Wei J; Uppal A; Nganjimi C; Warr H; Ibrahim Y; Gu Q; Yuan H; Rahman NM; Jones N; Walker AS; Eyre DW
    J Infect; 2024 Jun; 88(6):106161. PubMed ID: 38663754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance associations with national primary care antibiotic stewardship policy: Primary care-based, multilevel analytic study.
    Hammond A; Stuijfzand B; Avison MB; Hay AD
    PLoS One; 2020; 15(5):e0232903. PubMed ID: 32407346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
    Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
    Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
    Koh SWC; Ng TSM; Loh VWK; Goh JC; Low SH; Tan WZ; Wong HC; Durai P; Sun LJ; Young D; Tambyah PA
    Antimicrob Resist Infect Control; 2023 Aug; 12(1):73. PubMed ID: 37528415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.
    Blandy O; Honeyford K; Gharbi M; Thomas A; Ramzan F; Ellington MJ; Hope R; Holmes AH; Johnson AP; Aylin P; Woodford N; Sriskandan S
    J Hosp Infect; 2019 Feb; 101(2):120-128. PubMed ID: 30403958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.